Literature DB >> 10216475

Phospholipase D activity in human gastric carcinoma.

N Uchida1, S Okamura, H Kuwano.   

Abstract

Growth factor-stimulated phospholipase D (PLD) catalyzes the hydrolysis of phosphatidylcholine, generating phosphatidic acid which may act as a second messenger during cell proliferation, therefore PLD is believed to play an important role in tumorigenesis. Thus we measured PLD activity in human gastric carcinoma to evaluate its role in gastric carcinogenesis. PLD activity was assayed by a unique transphosphatidylation reaction using microsomal fraction of 21 pairs of surgically resected human gastric carcinomas and adjacent noncancerous mucosas. The mean PLD activities in gastric carcinoma and adjacent noncancerous mucosa were 63.0 +/- 69.5, 44.2 +/- 60.1 pmol/min/mg, respectively (p < 0.01; Wilcoxon signed rank test). The mean ratio of PLD activity in gastric carcinoma and adjacent noncancerous mucosa was 1.63. This ratio was significantly higher in patients with larger tumors (> or = 5 cm) (p < 0.01; Mann-Whitney U-test). Our results indicate that the elevation of PLD activity plays an important role in the promotion of gastric carcinoma.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10216475

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  39 in total

Review 1.  Phosphatidic acid signaling to mTOR: signals for the survival of human cancer cells.

Authors:  David A Foster
Journal:  Biochim Biophys Acta       Date:  2009-03-02

2.  Rebamipide-induced downregulation of phospholipase D inhibits inflammation and proliferation in gastric cancer cells.

Authors:  Dong Woo Kang; Gyesik Min; Do Yoon Park; Ki Whan Hong; Do Sik Min
Journal:  Exp Mol Med       Date:  2010-08-31       Impact factor: 8.718

3.  High Expression of PhospholipaseD2 Induced by Hypoxia Promotes Proliferation of Colon Cancer Cells through Activating NF- κ Bp65 Signaling Pathway.

Authors:  Maoxi Liu; Kunli Du; Bo Jiang; Xingye Wu
Journal:  Pathol Oncol Res       Date:  2018-08-08       Impact factor: 3.201

Review 4.  Chemical modulation of glycerolipid signaling and metabolic pathways.

Authors:  Sarah A Scott; Thomas P Mathews; Pavlina T Ivanova; Craig W Lindsley; H Alex Brown
Journal:  Biochim Biophys Acta       Date:  2014-01-15

Review 5.  Phospholipase D/phosphatidic acid signal transduction: role and physiological significance in lung.

Authors:  Rhett Cummings; Narasimham Parinandi; Lixin Wang; Peter Usatyuk; Viswanathan Natarajan
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

6.  Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part II. Identification of the 1,3,8-triazaspiro[4,5]decan-4-one privileged structure that engenders PLD2 selectivity.

Authors:  Robert Lavieri; Sarah A Scott; Jana A Lewis; Paige E Selvy; Michelle D Armstrong; H Alex Brown; Craig W Lindsley
Journal:  Bioorg Med Chem Lett       Date:  2009-03-06       Impact factor: 2.823

Review 7.  Targeting phospholipase D with small-molecule inhibitors as a potential therapeutic approach for cancer metastasis.

Authors:  Wenjuan Su; Qin Chen; Michael A Frohman
Journal:  Future Oncol       Date:  2009-11       Impact factor: 3.404

8.  Inhibition of phospholipaseD2 increases hypoxia-induced human colon cancer cell apoptosis through inactivating of the PI3K/AKT signaling pathway.

Authors:  Maoxi Liu; Zhongxue Fu; Xingye Wu; Kunli Du; Shouru Zhang; Li Zeng
Journal:  Tumour Biol       Date:  2015-11-27

9.  Thematic minireview series on phospholipase D and cancer.

Authors:  Julian Gomez-Cambronero; George M Carman
Journal:  J Biol Chem       Date:  2014-07-02       Impact factor: 5.157

10.  Phospholipase D elevates the level of MDM2 and suppresses DNA damage-induced increases in p53.

Authors:  Li Hui; Tarek Abbas; Rafal M Pielak; Troy Joseph; Jill Bargonetti; David A Foster
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.